Pharmacy insights

Articles and posts around pharmacy in UK. Some areas covered includes news around drugs, their developments, drug effectiveness, statistical information on drug issuing and legal aspect of the pharmacy.

  • Lemborexant (Davigo) by Eisai new sleeping pill
    Pharmacy insights

    Lemborexant a New Sleeping Pill Approved

    Lemborexant (brand name: DAYVIGO™), developed by Eisai, a Japanese pharmaceutical company, was recently approved in the US for the treatment of insomnia with symptoms of difficulty in falling asleep or maintaining the sleep during the night. Although there is a number of prescription medications used in the UK for the management of insomnia, Lemborexant’s mechanism of action differs from drugs currently available in the UK. Will Lemborexant be available in the UK? How does it work? Is Lemborexant effective, and how does it compare to commonly used Zolpidem in the treatment of insomnia? Can you be dependent on Lemborexant? These are some of the questions I will answer in this…

  • Pharmacy insights

    15 Most Prescribed Drugs in the UK

    In this post, I am looking at the most prescribed drugs in the UK. In brief, I review their indicated use and comment on possible causes of drug popularity.  15 most prescribed drugs in the UK are used for the treatment of the following conditions: Cholesterol-lowering drugs: Atorvastatin, Simvastatin Hypothyroidism: hormone Levothyroxine  Gastro-oesophageal reflux disease (GORD): Proton Pump Inhibitors (PPIs) including Omeprazole and Lansoprazole Cardiovascular drugs:  High blood pressure drugs: Amlodipine, Ramipril  Heart failure, angina: Bisoprolol Anti-diabetic drugs: Metformin Asthma: Salbutamol Painkillers: Co-codamol and paracetamol

  • Ranitidine cancer risk. Recall of ranitidine drug/
    Advice for patients,  Pharmacy insights

    Ranitidine Cancer RISK: why was ranitidine recalled?

    Ranitidine and cancer risk: a scary thought for many patients. Global market for ranitidine has been in turmoil in recent months, due to number of ranitidine recalls (including branded Zantac) by The U.S. Food and Drug Administration (FDA) in the US and shortly afterward, in UK. The Medicines and Healthcare Regulatory Agency (MHRA) recalled number of ranitidine products due to possible contamination with N-nitrosodimethylamine (NDMA), which has genotoxic and carcinogenic potential, a substance that could possibly cause cancer. Ranitidine – cancer scare was born. Note: Ranitidine (the chemical) does not have carcinogenic potential, but NDMA, a contaminant, which was found in many ranitidine containing products (tablets). Ranitidine is a commonly…

  • Flu jab cost by main UK pharmacies
    Pharmacy insights

    Flu jab cost 2019-2020

    Since 2015 community pharmacies in the UK are able to provide flu vaccination service to NHS patients. Year on year this service became increasingly popular. Last year a record number of flu jabs were provided by community pharmacist with an estimated 1.4 mln vaccinations administered as part of NHS service. This number does not include flu jabs administered on the basis of a private service. Patients who are not eligible to receive a free NHS flu jab can use private service to receive a vaccination for which patients pay. Prices for flu jab  varies between each pharmacy/pharmacy chain. Below is a summary of the main pharmacies and associated flu jab…

  • Flu vaccines 2019/2020
    Pharmacy insights

    Flu jabs 2019/2020 delays in supply

    In one of my previous posts, I summarised vaccine availability for upcoming flu season 2019/2020. During upcoming season we will see new flu vaccinations, however, we now know that there are already delays in the production of quadrivalent influenza flu vaccine affecting the delivery of service in some eligible patients.

  • Flu jab cost by main UK pharmacies
    Pharmacy insights

    Flu vaccines 2019 / 2020

    Last year, during 2018/2019 flu season, community pharmacist delivered over 1.4 mln flu vaccinations to patients under NHS Flu Vaccination Service (PSNC, n.d.). Although flu season 2019/2020 seems far away, updated details for this service and flu vaccines 2019 /2020 are already known.

  • Plenity weight loss pill
    Drug reviews,  Pharmacy insights

    Plenity a New Weight Loss Pill

    I must admit, the topic of this post is rather inaccurate. Plenity is a capsule (not a pill) that can be used to aid weight loss in adults who are obese or overweight in combination with diet and exercise (US licensing). Plenity is not a new product. Previously known as Attiva (and Gelesis 100), Plenty was subject to clinical trial back in 2010. Recently, the FDA approved Plenity to help with weight management as detailed in the first paragraph.

  • Pharmacy insights

    Flibanserin (Addyin) in the UK

    In this post, I will be looking at FDA approved Flibanserin (Addyin) drug with the emphasis on the effectives behind the treatment and its availability in the UK. Flibanserin available under the branded name of Addyi is FDA approved (USA) drug for the treatment of premenopausal women (women who have not gone through menopause) with hypoactive (low) sexual desire disorder (HSDD).

  • Advice for patients,  Pharmacy insights

    Drugs that keep you awake: modafinil

    Modafinil is the main focus of today’s post. It will be part of posts on prescription drugs that keep you awake and/or affect cognitive performance. I will summarise the mechanism of action of each drug in relation to wakefulness and possible effects on cognitive performance and whether they fall into ‘smart drug’ category. Smart drugs have been attracting a larger audience in recent years among students, bankers and shift workers. It is a known fact that armies around the world use stimulants to improve performance during a long duration missions (Bower, 2003). Movies like Limitless contributed to greater interest in smart drugs, particularly modafinil which received a label of NZT-48…

  • Prescription sleeping pills UK
    Pharmacy insights

    Prescription Sleeping Pills: 7 most commonly used drugs

    In one of my previous posts I analysed prescribing patterns for antidepressant drugs in UK, where sharp increase of antidepressant use in UK is seen. In today’s post I will be looking at prescribing statistics for prescription sleeping pills, used for treatment of insomnia. Insomnia can be one of the symptoms of depression. Does sharp increase of antidepressant prescribing correlate with increase in the use of prescription sleeping tablets in recent years? Prescribing data used for this review was taken from OpenPrescribing.net